drugset / Trial / NCT01768013

The Pharmacokinetics of LEO 90105 (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Extensive Psoriasis Vulgaris

NCT01768013

Phase 1/2 Completed 13 enrolled LEO Pharma
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The pharmacokinetics of LEO 90105 (calcipotriol hydrate plus betamethasone dipropionate) in Japanese subjects with extensive psoriasis vulgaris.

Timeline

Start
2012-07
Primary completion
2012-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Calcipotriol Small molecule
Subject betamethasone dipropionate Small molecule

Indications